Bimzelx (Bimekizumab) For The Treatment Of Adult Onset PRP | MicrobiomeTrials← Back to trialsNCT07497620
Bimzelx (Bimekizumab) For The Treatment Of Adult Onset PRP
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-07-01Est. Completion: 2027-08-01
Enrollment target: 12 participants Locations- Mayo Clinic in Florida, Jacksonville, Florida, United States
Other microbiome trials you might be interested in
Pityriasis Rubra Pilaris
The purpose of this study is to evaluate the safety and effectiveness of Deucravacitinib (BMS-986165) in Pityriasis Rubr…
Scottsdale, United StatesCompleted Sep 2, 2025
Pityriasis Rubra Pilaris
15 patients with PRP will be treated with guselkumab for 20 weeks to determine safety and efficacy. Participants are req…
Portland, United StatesCompleted Aug 11, 2022